Adalimumab for the Treatment of Periodontitis in a 35-Year-Old Woman with Hidradenitis Suppurativa

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Adalimumab for the Treatment of Periodontitis in a 35-Year-Old Woman with Hidradenitis Suppurativa. / Yao, Yiqiu; Ghazanfar, Misbah Noshela; Jørgensen, Astrid Helene Ravn; Ring, Hans Christian; Thomsen, Simon Francis.

I: Case Reports in Dermatology, Bind 15, Nr. 1, 2023, s. 5-9.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Yao, Y, Ghazanfar, MN, Jørgensen, AHR, Ring, HC & Thomsen, SF 2023, 'Adalimumab for the Treatment of Periodontitis in a 35-Year-Old Woman with Hidradenitis Suppurativa', Case Reports in Dermatology, bind 15, nr. 1, s. 5-9. https://doi.org/10.1159/000528139

APA

Yao, Y., Ghazanfar, M. N., Jørgensen, A. H. R., Ring, H. C., & Thomsen, S. F. (2023). Adalimumab for the Treatment of Periodontitis in a 35-Year-Old Woman with Hidradenitis Suppurativa. Case Reports in Dermatology, 15(1), 5-9. https://doi.org/10.1159/000528139

Vancouver

Yao Y, Ghazanfar MN, Jørgensen AHR, Ring HC, Thomsen SF. Adalimumab for the Treatment of Periodontitis in a 35-Year-Old Woman with Hidradenitis Suppurativa. Case Reports in Dermatology. 2023;15(1):5-9. https://doi.org/10.1159/000528139

Author

Yao, Yiqiu ; Ghazanfar, Misbah Noshela ; Jørgensen, Astrid Helene Ravn ; Ring, Hans Christian ; Thomsen, Simon Francis. / Adalimumab for the Treatment of Periodontitis in a 35-Year-Old Woman with Hidradenitis Suppurativa. I: Case Reports in Dermatology. 2023 ; Bind 15, Nr. 1. s. 5-9.

Bibtex

@article{78018f268f59479581de2eb2cfb5faa2,

title = "Adalimumab for the Treatment of Periodontitis in a 35-Year-Old Woman with Hidradenitis Suppurativa",

abstract = "Increasing evidence suggests an association between chronic inflammatory conditions and oral health. Herein, we present a case of a 35-year-old woman with concomitant hidradenitis suppurativa (HS) and periodontitis, who was treated successfully with adalimumab. After 3 months of treatment, a marked improvement was observed in her clinical scores of HS, quality of life, as well as her gingival pain and signs of inflammation. This finding calls for a closer collaboration between dermatologists and dentists to further explore the possible beneficial role of biologic therapy for chronic inflammatory skin conditions as well as periodontitis. ",

keywords = "Adalimumab, Hidradenitis suppurativa, Inflammation, Periodontitis",

author = "Yiqiu Yao and Ghazanfar, {Misbah Noshela} and J{\o}rgensen, {Astrid Helene Ravn} and Ring, {Hans Christian} and Thomsen, {Simon Francis}",

note = "Publisher Copyright: {\textcopyright} 2023 The Author(s).",

year = "2023",

doi = "10.1159/000528139",

language = "English",

volume = "15",

pages = "5--9",

journal = "Case Reports in Dermatology",

issn = "1662-6567",

publisher = "S Karger AG",

number = "1",

}

RIS

TY - JOUR

T1 - Adalimumab for the Treatment of Periodontitis in a 35-Year-Old Woman with Hidradenitis Suppurativa

AU - Yao, Yiqiu

AU - Ghazanfar, Misbah Noshela

AU - Jørgensen, Astrid Helene Ravn

AU - Ring, Hans Christian

AU - Thomsen, Simon Francis

PY - 2023

Y1 - 2023

N2 - Increasing evidence suggests an association between chronic inflammatory conditions and oral health. Herein, we present a case of a 35-year-old woman with concomitant hidradenitis suppurativa (HS) and periodontitis, who was treated successfully with adalimumab. After 3 months of treatment, a marked improvement was observed in her clinical scores of HS, quality of life, as well as her gingival pain and signs of inflammation. This finding calls for a closer collaboration between dermatologists and dentists to further explore the possible beneficial role of biologic therapy for chronic inflammatory skin conditions as well as periodontitis.

AB - Increasing evidence suggests an association between chronic inflammatory conditions and oral health. Herein, we present a case of a 35-year-old woman with concomitant hidradenitis suppurativa (HS) and periodontitis, who was treated successfully with adalimumab. After 3 months of treatment, a marked improvement was observed in her clinical scores of HS, quality of life, as well as her gingival pain and signs of inflammation. This finding calls for a closer collaboration between dermatologists and dentists to further explore the possible beneficial role of biologic therapy for chronic inflammatory skin conditions as well as periodontitis.

KW - Adalimumab

KW - Hidradenitis suppurativa

KW - Inflammation

KW - Periodontitis

U2 - 10.1159/000528139

DO - 10.1159/000528139

M3 - Journal article

C2 - 36619701

AN - SCOPUS:85181688753

VL - 15

SP - 5

EP - 9

JO - Case Reports in Dermatology

JF - Case Reports in Dermatology

SN - 1662-6567

IS - 1

ER -

ID: 379797394